Jardiance label adds CV risk indication

FDA approved Jardiance empagliflozin from Boehringer Ingelheim GmbH (Ingelheim, Germany) and Eli Lilly and Co. (NYSE:LLY) to reduce

Read the full 183 word article

User Sign In